Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Government health plans in the U.S. provide significant coverage for new weight-loss drugs, overshadowing private insurers.

Wegovy's approval by China's NMPA targets individuals with a BMI of 30+ with related health issues; initial supply will be ...

Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy, Ozempic, and Rybelsus and similar drugs like Moujaro and Zepbound. And just like all the other weight ...

An Arkansas Legislative Council subcommittee has recommended that the state's health insurance plans for public school and ...

Fox News medical contributor Dr. Nicole Saphier said changing America's food system is "not going to be an easy fix" while ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...